Table 2 Treatment, follow-up duration, and adverse events
Patient no. | Treatments associated with azithromycin | Azithromycin treatment duration (months) | Follow-up without azithromycin (months) | Adverse event |
|---|---|---|---|---|
1 | LH | 6 | 8 | |
2 | LH | 4 | 9 | |
3 | LH | 6 | 12 | Moderate ocular redness upon instillation |
4 | LH, topical cyclosporine added at month 5 for 5 months | 10 | 11 | Important burning, treatments stopped at month 10 |
5 | LH | 6 | 9 | Mild stinging upon instillation |
6 | LH | 5 | 13 | |
7 | LH | 6 | 9 | |
8 | LH | 8 | 12 | |
9 | LH | 4 | 10 | Mild stinging upon instillation |
10 | LH | 6 | 11 | |
11 | LH | 6 | 9 | |
12 | LH | 6 | 12 | Moderate ocular redness upon instillation |
13 | LH | 6 | 10 | |
14 | LH | 6 | 11 | |
15 | LH | 6 | 12 | |
16 | LH | 5 | 14 | Important burning, treatment stopped at month 5 |